Basic cellular mechanisms of coronary bypass graft disease

Area of Science:

• Cardiovascular Surgery
• Vascular Biology
• Biomedical Engineering

Background:

• Internal mammary artery (IMA) grafts exhibit higher patency rates than saphenous vein (SV) grafts in coronary artery bypass surgery.
• Graft performance is significantly influenced by the biological properties of endothelial and smooth muscle cells within the grafts.

Purpose of the Study:

• To investigate the distinct endothelial and smooth muscle cell functions of IMA and SV grafts.
• To elucidate how these cellular differences contribute to the observed variations in graft patency and function in patients with coronary artery disease.

Main Methods:

• Comparative analysis of endothelial cell function, focusing on nitric oxide production in response to vasoactive stimuli.
• Assessment of smooth muscle cell proliferation in response to mechanical forces and growth factors.
• Evaluation of platelet-derived signaling pathways impacting graft vasoconstriction and relaxation.

Main Results:

• IMA endothelial cells release greater amounts of nitric oxide (NO) from L-arginine, promoting vascular relaxation, unlike SV grafts.
• Platelet-derived adenosine nucleotides activate NO release in IMA, a mechanism absent in SV.
• SV smooth muscle cells demonstrate greater proliferation in response to pulsatile stretch and platelet-derived growth factor, contributing to intimal thickening.

Conclusions:

• Differential endothelial cell function, particularly nitric oxide production, significantly impacts graft patency.
• Variations in smooth muscle cell response to mechanical stimuli and growth factors contribute to intimal hyperplasia and occlusion in SV grafts.
• The distinct cellular biology of IMA and SV explains their differing functional outcomes in coronary artery bypass grafting.